SlideShare a Scribd company logo
PRESIDENTIAL ACTION PLAN 2018
Ref:
INFECTIVE ENDOCARDITIS IN CHILDREN
MURTAZA KAMAL
5TH JAN, 2019
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Definition
 Epidemiology
 Pathogenesis/ Pathology/ Microbiology
 Clinical features
 Diagnosis & Diagnostic criteria
 Treatment
 Preventive methods
Scope of the talk…
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Microbial infection of endocardial (endothelial) surface of heart
 Native/ prosthetic valves: Most frequently involved
 Can involve septal defects, mural endocardium, intravascular
foreign devices, intracardiac patches, surgically constructed
shunts, IV catheters
 Disease classification on basis of etiologic agent involved:
 Low virulence organisms (Alpha hemolytic streptococcai,
enterococci, CONS): Prolonged subacute form of illness
 Virulent organisms (Staph aureus, strept pneumoniae, beta
hemolytic streptococci): Acute clinical course
Definition
Gewitz M, Taubert KA. IE and prevention. In: Heart disease in infant, children andadolescents. 9th ed. Philadelphia:
Wolter Kluwer; 2016: 1441-1453
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Less often in children than in adults
 1: 1280 (0.78/1000) paediatric admissions/ year
 Overall frequency among children and a shift towards those with
previous cardiac surgery: Increased Improved survival among
children who are at risk of IE, such as those with CHD (with/
without surgery) and hospitalised neonates
 CHD: Predominant underlying condition in developed world (MC:
VSD, TOF, aortic valve abnormalities)
 Post operative IE: Long term risk after correction of complex CHD,
esp those with residual defects/ surgical shunts/ prosthetic
materials
Epidemiology
Van Hare GF, Ben-Shachar G, Liebman J, Boxerbaum B, RiemenschneiderTA. Infective endocarditis in infants and children during the past 10 years:
a decade of change. Am Heart J. 1984;107:1235–1240.
Pasquali SK, He X, Mohamad Z, McCrindle BW, Newburger JW, Li JS,Shah SS. Trends in endocarditis hospitalizations at US children’s hospitals:
impact of the 2007 American Heart Association antibiotic prophylaxisguidelines. Am Heart J 2012;143:894–899.
PRESIDENTIAL ACTION PLAN 2018
Ref:
 RHD: Before 1970s, 30-50% children with IE  Decreased now as
prevalence of RHD decreased in developed countries
 8-10% of pediatric cases: IE develops without structural heart
disease: Central indwelling venous catheters Mostly aortic or
mitral valves are involved by staph aureus
 Neonates: 7.3% cases: Right sided heart structures involved
 Factors associated with IE in adults like IV drug abuse and
degenerative heart diseases: Not common predisposing factor
Epidemiology Cont…
Baltimore RS. Infective endocarditis. In: Jenson HB, Baltimore RS,eds. Pediatric Infectious Diseases: Principles and Practice. 2nd ed.
Philadelphia, PA: Saunders; 2002.
Stull TL, LiPuma JJ. Endocarditis in children. In: Kaye D, ed. InfectiveEndocarditis. 2nd ed. New York, NY: Raven Press; 1992:313–327
Stockheim JA, Chadwick EG, Kessler S, Amer M, Abdel-Haq N, DajaniAS, Shulman ST. Are the Duke criteria superior to the Beth Israel criteria
for the diagnosis of infective endocarditis in children? Clin Infect Dis.1998;27:1451–1456.
PRESIDENTIAL ACTION PLAN 2018
Ref:
 2 important factors:
 Damaged area of endothelium and
 Bacteremia (even transient)
 Structural abnormalities of heart/ great arteries+ significant
pressure gradient/ turbulence Endothelial damage Thrombus
formation with deposition of sterile clumps of platelet and fibrin
Nonbacterial thrombus Nidus for bacteria to adhere and form
infected vegetation
 Bacteremia from dental procedures
 Bacteremia with activities such as chewing/ brushing teeth
 Chewing with diseased teeth or gums frequent cause of bacteremia
 Good dental hygiene very important in prevention
Pathogenesis
PRESIDENTIAL ACTION PLAN 2018
Ref:
Vegetation:
 Usually on low-pressure side of defect
 Either around defect or on opposite surface of defect where
endothelial damage is established by jet effect of defect
 Vegetations found in PA in PDA or systemic-to-PA shunts
 On atrial surface of mitral valve in MR
 On ventricular surface of aortic valve and mitral chordae in
AR
 On superior surface of aortic valve or at site of a jet lesion in
aorta in AS
Pathology
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Streptococcus viridans, Enterococci and Staphylococcus
aureus: 50%- 60%
 Fungi+ HACEK organisms (Haemophilus, Actinobacillus,
Cardiobacterium, Eikenella, and Kingella spp.): 17% to 30%
 α-Hemolytic streptococci (S. viridans): Dental procedures/
carious teeth/ periodontal disease
 Enterococci: After GU/ GI surgery/ instrumentation
 Staphyloccocci: Postoperative endocarditis
 S. aureus: IV drug abusers
 Fungal endocarditis (poor prognosis): Sick neonates/ long-
term antibiotic or steroid therapy/ after open heart surgery
 Fungal endocarditis: Associated with very large friable
vegetations; emboli from these vegetations frequently
produce serious complications
Microbes: The Agent
PRESIDENTIAL ACTION PLAN 2018
Ref:
 S. aureus/ CONS: Indwelling vascular catheters/ prosthetic material/
prosthetic valves
 S. aureus/ CONS/ Candida: MCC among newborn infants
 Culture-negative endocarditis: 5-7%
 Patient has clinical or echo evidence of endocarditis but
persistently negative blood culture results
 MCC: Current or recent antibiotic therapy or infection caused
by a fastidious organism that grows poorly in vitro
 Fungal endocarditis: A rare cause of culture-negative
endocarditis
 Diagnosis can be made only by removal of vegetation (during
surgery) sometimes
Microbes: The Agent…
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Most patients have history of underlying heart defect
 Some patients with bicuspid aortic valve may not have been diagnosed
with defect before
 History of a recent dental procedure/ tonsillectomy / toothache (from
dental or gingival disease)
 Endocarditis: Rare in infancy; at this age, usually follows open heart
surgery
 Onset usually insidious with prolonged low-grade fever and somatic
complaints, fatigue, weakness, loss of appetite, pallor, arthralgia,
myalgias, weight loss, and diaphoresis
Clinical Features: History
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Heart murmur: Universal (100%)
 Appearance of new heart murmur/ Increase in intensity of an
existing murmur
 Fever: 80%–90%; 101° and 103°F
 Splenomegaly: 70%
 Skin manifestations: 50%; Either secondary to microembolization or as
an immunologic phenomenon:
 Petechiae on skin/ mucous membranes/ conjunctivae
 Osler’s nodes: Tender, pea-sized red nodes at ends of fingers/
toes
 Janeway’s lesions: Small, painless, hemorrhagic areas on palms/
soles
 Splinter hemorrhages: Linear hemorrhagic streaks beneath
nails
Clinical Features: Examination
CLINICAL FEATURES: EXAMINATION
Osler Nodes Janeway lesion
From AAP. Red Book Online visual library, 2006
PRESIDENTIAL ACTION PLAN 2018
Ref:
Clinical Features: Examination
 Embolic/ immunologic phenomena in other organs: 50%
 Pulmonary emboli: VSD, PDA or a systemic-to-PA shunt
 Seizures and hemiparesis: Embolization to CNS-20%
 Hematuria and renal failure
 Roth’s spots- 5%:
Oval, retinal hemorrhages
with pale centers located
near optic disc
From AAP. Red Book Online visual library, 2006
PRESIDENTIAL ACTION PLAN 2018
Ref:
Clinical Features: Examination
 Clubbing of fingers in absence of cyanosis rarely in chronic cases
 Heart failure as a complication of infection
 Neonate:
 Nonspecific and may be indistinguishable from septicemia or CHF
from other causes
 Embolic phenomena (osteomyelitis, meningitis) common
 Neurologic signs and symptoms (seizures,hemiparesis, apnea)
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Positive blood cultures:
 90% in absence of previous antimicrobial therapy
 50-60% pretreatment with antibiotics
 CBC:
 Anemia: 80%
 Leukocytosis with a shift to the left
 Patients with polycythemia preceding onset of IE may
have normal hemoglobin
 ESR: Increased unless there is polycythemia.
 Microscopic hematuria: 30%
Lab Studies
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Main modality for detection
 Site of infection, extent of valvular damage and cardiac function
 Baseline evaluation of ventricular function and cardiac chamber
dimension important for comparison later
 Color Doppler: Sensitive modality for detection of valvular
regurgitation
Role of ECHOCARDIOGRAPHY
Vegetations on the aortic valve
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Echocardiographic findings included as major criteria in
modified Duke criteria:
 Oscillating intracardiac mass on valves or supporting
structures, in path of regurgitation jets, or on
implanted material
 Abscesses
 New partial dehiscence of prosthetic valve
 New valvular regurgitation
Role of ECHOCARDIOGRAPHY
PRESIDENTIAL ACTION PLAN 2018
Ref:
 TEE superior to TTE:
 Vegetations on prosthetic valves
 Detecting complications of LV outflow tract endocarditis
 Detecting aortic root abscess and involvement of sinus of
Valsalva
 Absence of vegetations on echo: Does not rule out IE
 False-negative: Vegetations are small or have embolized and they
may miss initial perivalvular abscess
 Repeat examinations indicated if suspicion exists without
diagnosis of IE or worrisome clinical course during early
treatment of IE
Role of ECHOCARDIOGRAPHY
PRESIDENTIAL ACTION PLAN 2018
Ref:
 False-positive:
 An echogenic mass may represent a sterile
thrombus, sterile prosthetic material, normal
anatomic variation, an abnormal uninfected valve
(previous scarring, severe myxomatous changes),
or improper gain of echo machine
 Echocardiographic evidence of vegetation may persist for
months or years after bacteriologic cure
Role of ECHOCARDIOGRAPHY
PRESIDENTIAL ACTION PLAN 2018
Ref:
Echocardiographic Features Suggesting
Potential Need for Surgical Intervention
Bayer et al.102 Copyright © 1998, American Heart Association, Inc.
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Definite IE :
 Pathological evidence of IE:
 Demonstration of microorganism by culture
 Histology in a vegetation or from an embolic sites or an
intracardiac abscess or histologic evidence of active
endocarditis demonstrated in vegetation or
intracardiac abscess
 Fulfillment of clinical criteria:
 2 major criteria
 1 major+ 3 minor criteria
 5 minor criteria
DIAGNOSIS: Modified Dukes Criteria
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Possible IE: When one of the following is present:
 1 major+ 1 minor criterion
 3 minor criteria
 Rejected IE:
 An alternative diagnosis is established
 Clinical manifestations of IE have resolved within
4 days of antibiotic therapy
 No pathological evidence is found on direct
examination of vegetation obtained from surgery
or autopsy after antibiotic therapy for < 4 days
 Criteria for possible IE are not met
DIAGNOSIS: Modified Dukes Criteria
PRESIDENTIAL ACTION PLAN 2018
Ref:
1. Blood culture positive for IE:
 Typical microorganisms consistent with IE from 2 separate
blood cultures: Viridans streptococci, Streptococcus bovis,
HACEK group, Staphylococcus aureus; or community-
acquired enterococci in absence of a primary focus or
 Microorganisms consistent with IE from persistently positive
blood cultures defined as: at least 2 positive cultures of
blood samples drawn >12 h apart or all of 3 or a majority of 4
or more separate cultures of blood (with first and last sample
drawn at least 1 h apart)
 Single positive blood culture for Coxiella burnetii or anti–
phase 1 IgG antibody titer >1:800
Modified Dukes: Major Criteria
PRESIDENTIAL ACTION PLAN 2018
Ref:
2. Evidence of endocardial involvement
 Echocardiogram positive for IE (TEE recommended for
patients with prosthetic valves, rated at least “possible IE”
by clinical criteria, or complicated IE [paravalvular abscess];
TTE as first test in other patients) defined as follows:
 Oscillating intracardiac mass on valve or supporting
structures, in path of regurgitant jets, or on implanted
material in absence of an alternative anatomic explanation
 Abscess
 New partial dehiscence of prosthetic valve
 New valvular regurgitation (worsening or changing or
preexisting murmur not sufficient)
Modified Dukes: Major Criteria
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Predisposition, predisposing heart condition, or IDU
 Fever, temperature >38°C
 Vascular phenomena: Major arterial emboli, septic pulmonary
infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival
hemorrhages and Janeway’s lesions
 Immunologic phenomena: Glomerulonephritis, Osler’s nodes,
Roth’s spots and rheumatoid factor
 Microbiologic evidence: Positive blood culture but does not meet a
major criterion or serologic evidence of active infection with
organism consistent with IE
Modified Dukes: Minor Criteria
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Blood cultures: Indicated for all patients with fever of unexplained
origin and a pathologic heart murmur, a history of heart disease or
previous endocarditis
 Usually 3 blood cultures are drawn by separate venipunctures over 24
hours unless patient is very ill
 90% of cases, causative agent is recovered from 1st 2 cultures
 If no growth by 2nd day of incubation, 2 more may be obtained
 No value in obtaining >5 blood cultures over 2 days unless patient
received prior antibiotic therapy
 Not necessary to obtain cultures at any particular phase of fever cycle
 Adequate volume: 1-3 mL infants; 5-7 mL older children
 Aerobic incubation alone sufficient
Management
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Recommended that consultation from local infectious disease
specialist be obtained when IE suspected/confirmed: Antibiotics of
choice continually changing, and there may be special situation
pertaining to local area
 Initial empirical therapy:
 Usual initial regimen: Antistaphylococcal semisynthetic
penicillin (nafcillin,oxacillin or methicillin)+ aminoglycoside
(gentamicin)
 Covers against S. viridans, S. aureus, and gram-negative
organisms
 Vancomycin:
 Methicillin-resistant S. aureus suspected
 Penicillin-allergic patients
Management
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Depends on organism isolated+ results of antibiotic sensitivity test
 Streptococcal IE:
 Native cardiac valve IE caused by highly sensitive S. viridans:
 IV penicillin (or ceftriaxone OD) X 4 weeks
 Alternatively penicillin, ampicillin or ceftriaxone+
gentamicin for 2 weeks
 IE caused by penicillin-resistant streptococci:
 4 weeks of penicillin, ampicillin or ceftriaxone+
gentamicin for 2 weeks
Final antibiotic selection
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Staphylococcal endocarditis:
 Drug of choice native valve IE by methicillin-susceptible
staphylococci: Semisynthetic β-lactamase–resistant penicillins
(nafcillin, oxacillin or methicillin) X minimum of 6 weeks (±
gentamicin X 3–5 days)
 Methicillin-resistant native valve IE: Vancomycin X 6 weeks (±
gentamicin X 3–5 days)
 Enterococcus:
 IV penicillin/ ampicillin+ gentamicin X 4 to 6 weeks
 Allergic to penicillin: Vancomycin +gentamicin x 6 weeks
 HACEK organisms:
 Ceftriaxone/ another 3rd generation cephalosporin alone or
ampicillin+ gentamicin x 4 weeks
Final antibiotic selection
PRESIDENTIAL ACTION PLAN 2018
Ref:
 IE by other gram-negative bacteria (E coli, Pseudomonas
aeruginosa, or Serratia marcescens):
 Piperacillin/ ceftazidime together+ gentamicin X 6 weeks
 Amphotericin B: Most effective agent for most fungal infections
 Culture-negative endocarditis:
 Treatment directed against staphylococci, streptococci and
HACEK organisms using ceftriaxone+ gentamicin
 When staphylococcal IE suspected, nafcillin should be
added to the above therapy
Final antibiotic selection
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Should be treated for 6 weeks based on organism isolated
and results of sensitivity test
 Operative intervention may be necessary before antibiotic
therapy is completed if clinical situation warrants:
 Progressive CHF
 Significant malfunction of prosthetic valves
 Persistently positive blood cultures after 2 weeks of
therapy
 Bacteriologic relapse after an appropriate course of
therapy
Prosthetic valve Endocarditis
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Overall recovery rate: 80%- 85%
 90% or better: S. viridans and enterococci
 50%: Staphylococcus organisms
 Fungal endocarditis: Very poor outcome
Prognosis
PRESIDENTIAL ACTION PLAN 2018
Ref:
Prevention
 Emphasis should be on maintaining good oral hygiene and
eradicating dental disease to decrease frequency of
bacteremia from routine daily activities
 Recommended for tonsillectomy and adenoidectomy only in
high-risk patients
 Prophylaxis no longer recommended:
 For routine bronchoscopy
 For GI or genitourinary procedures, such as diagnostic
esophagogastroduodenoscopy or colonoscopy
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Patients with prosthetic cardiac valve/ material used for cardiac valve
repair
 Patients with previous IE
 Patients with CHD:
 Unrepaired cyanotic CHD, including palliative shunts/ conduits
 Completely repaired CHD with prosthetic material/ device,
whether placed by surgery or catheter intervention, during 1st
6 months after procedure
 Repaired CHD with residual defects at site or adjacent to site
of a prosthetic patch/ device (which inhibits
endothelialization)
 Cardiac transplantation recipients with valve regurgitation caused by
a structurally abnormal valve
Cardiac conditions for which prophylaxis
With dental procedures is recommended
PRESIDENTIAL ACTION PLAN 2018
Ref:
 Dental procedures:
 Involving manipulation of gingival tissue of periapical region
or perforation of oral mucosa
 Respiratory tract procedures:
 Procedures that involve incision/ biopsy of respiratory mucosa
 Not recommended for bronchoscopy
 GI or GU procedures:
 No prophylaxis for diagnostic esophagogastroduodenoscopy/
colonoscopy
 Reasonable in patients with infected GI/GU tract
 Skin, skin structure or musculoskeletal tissue:
 Surgical procedures that involve infected skin, skin structure,
or musculoskeletal tissue
Procedures for which IE
Prophylaxis is recommended
PRESIDENTIAL ACTION PLAN 2018
Ref:
Prophylactic regimens for
Dental procedures
Park. Pediatric cardiology for practitioners; 6th edition
PRESIDENTIAL ACTION PLAN 2018
Ref:
Special Considerations
 Patients already receiving antibiotics:
 Rheumatic fever prophylaxis: Use other antibiotics, such as
clindamycin, azithromycin or clarithromycin
 Delay a procedure until 10 days after completion of antibiotic
 Patients who undergo cardiac surgery:
 Careful preoperative dental evaluation so that required dental
treatment may be completed whenever possible before surgery
 Prophylaxis at time of surgery: Primarily against staphylococci
Prophylaxis should be initiated immediately before surgery,
repeated during prolonged procedures to maintain serum
concentrations intraoperatively, and continued for no more
than 48 hours postoperatively
PRESIDENTIAL ACTION PLAN 2018
Ref:
 IE in children is not uncommon
 Common in children with CHD
 Neonates: Poor outcome
 Blood culture + ECHO has important role in diagnosis
 Treatment adherence necessary
 Prognosis not bad if treated properly
 Knowledge of conditions requiring prophylaxis and drugs for it
necessary
Take Home Message
PRESIDENTIAL ACTION PLAN 2018
Ref:
THANK YOU

More Related Content

What's hot

NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN
Sajjad Sabir
 
Rheumatic fever & acute rheumatic heart disease Rheumatic fever & acute rhe...
Rheumatic fever & acute rheumatic heart disease 	 Rheumatic fever & acute rhe...Rheumatic fever & acute rheumatic heart disease 	 Rheumatic fever & acute rhe...
Rheumatic fever & acute rheumatic heart disease Rheumatic fever & acute rhe...MedicineAndFamily
 
Arrhythmias in children
Arrhythmias in childrenArrhythmias in children
Arrhythmias in children
apoorvaerukulla
 
Henoch scholein purpura
Henoch scholein purpuraHenoch scholein purpura
Henoch scholein purpura
Dr. Saad Saleh Al Ani
 
Approach to a child with Hepatosplenomegaly
Approach to a child with HepatosplenomegalyApproach to a child with Hepatosplenomegaly
Approach to a child with HepatosplenomegalySunil Agrawal
 
Chronic Kidney Disease in Pediatrics
Chronic Kidney Disease in PediatricsChronic Kidney Disease in Pediatrics
Chronic Kidney Disease in Pediatrics
Drhunny88
 
history and examination in pediatric CVS
history and examination in pediatric CVShistory and examination in pediatric CVS
history and examination in pediatric CVS
Raghav Kakar
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
Azad Haleem
 
Croup in children
Croup in childrenCroup in children
Croup in children
Dr. Saad Saleh Al Ani
 
Heart failure in childhood
Heart failure in childhoodHeart failure in childhood
Heart failure in childhood
Reyad Al_Faky
 
pediatrics congenital heart disease
pediatrics congenital heart diseasepediatrics congenital heart disease
pediatrics congenital heart disease
getandale zeleke
 
Acute kidney injury in children 2018
Acute kidney injury in children 2018Acute kidney injury in children 2018
Acute kidney injury in children 2018
Raghav Kakar
 
Hemolytic uremic syndrome
Hemolytic uremic syndromeHemolytic uremic syndrome
Hemolytic uremic syndromeNajib Suhrabi
 
Neonatal Cholestasis
Neonatal CholestasisNeonatal Cholestasis
Neonatal Cholestasis
Dr. Maimuna Sayeed
 
Acute rheumatic fever in Children
Acute rheumatic fever in ChildrenAcute rheumatic fever in Children
Acute rheumatic fever in Children
CSN Vittal
 
Acute Rheumatic Fever
Acute Rheumatic FeverAcute Rheumatic Fever
Acute Rheumatic Fever
Sue Ting Lim
 
Hemolytic anemia in children
Hemolytic anemia in childrenHemolytic anemia in children
Hemolytic anemia in children
Imran Iqbal
 
Pediatric Acute Liver Failure
Pediatric Acute Liver FailurePediatric Acute Liver Failure
Pediatric Acute Liver Failure
Aniruddha Ghosh
 
Kawasaki disease
Kawasaki diseaseKawasaki disease
Kawasaki disease
Manoj Prabhakar
 

What's hot (20)

NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN NEPHRITIC SYNDROME / APSGN IN CHILDREN
NEPHRITIC SYNDROME / APSGN IN CHILDREN
 
Rheumatic fever & acute rheumatic heart disease Rheumatic fever & acute rhe...
Rheumatic fever & acute rheumatic heart disease 	 Rheumatic fever & acute rhe...Rheumatic fever & acute rheumatic heart disease 	 Rheumatic fever & acute rhe...
Rheumatic fever & acute rheumatic heart disease Rheumatic fever & acute rhe...
 
Arrhythmias in children
Arrhythmias in childrenArrhythmias in children
Arrhythmias in children
 
Henoch scholein purpura
Henoch scholein purpuraHenoch scholein purpura
Henoch scholein purpura
 
Approach to a child with Hepatosplenomegaly
Approach to a child with HepatosplenomegalyApproach to a child with Hepatosplenomegaly
Approach to a child with Hepatosplenomegaly
 
Chronic Kidney Disease in Pediatrics
Chronic Kidney Disease in PediatricsChronic Kidney Disease in Pediatrics
Chronic Kidney Disease in Pediatrics
 
history and examination in pediatric CVS
history and examination in pediatric CVShistory and examination in pediatric CVS
history and examination in pediatric CVS
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
Croup in children
Croup in childrenCroup in children
Croup in children
 
Neonatal Cholestasis
Neonatal CholestasisNeonatal Cholestasis
Neonatal Cholestasis
 
Heart failure in childhood
Heart failure in childhoodHeart failure in childhood
Heart failure in childhood
 
pediatrics congenital heart disease
pediatrics congenital heart diseasepediatrics congenital heart disease
pediatrics congenital heart disease
 
Acute kidney injury in children 2018
Acute kidney injury in children 2018Acute kidney injury in children 2018
Acute kidney injury in children 2018
 
Hemolytic uremic syndrome
Hemolytic uremic syndromeHemolytic uremic syndrome
Hemolytic uremic syndrome
 
Neonatal Cholestasis
Neonatal CholestasisNeonatal Cholestasis
Neonatal Cholestasis
 
Acute rheumatic fever in Children
Acute rheumatic fever in ChildrenAcute rheumatic fever in Children
Acute rheumatic fever in Children
 
Acute Rheumatic Fever
Acute Rheumatic FeverAcute Rheumatic Fever
Acute Rheumatic Fever
 
Hemolytic anemia in children
Hemolytic anemia in childrenHemolytic anemia in children
Hemolytic anemia in children
 
Pediatric Acute Liver Failure
Pediatric Acute Liver FailurePediatric Acute Liver Failure
Pediatric Acute Liver Failure
 
Kawasaki disease
Kawasaki diseaseKawasaki disease
Kawasaki disease
 

Similar to INFECTIVE ENDOCARDITIS IN CHILDREN

IEPPT-IIIstd (2).pptx
IEPPT-IIIstd (2).pptxIEPPT-IIIstd (2).pptx
IEPPT-IIIstd (2).pptx
yilkalmossie1
 
infective endocarditis a complete presentation.ppt
infective endocarditis a complete presentation.pptinfective endocarditis a complete presentation.ppt
infective endocarditis a complete presentation.ppt
tejasnangalia07
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditispochao
 
Endocarditis.ppt
Endocarditis.pptEndocarditis.ppt
Endocarditis.ppt
JOICY45
 
Endocarditis fisiopatologia diagnóstico y tratamiento
Endocarditis fisiopatologia diagnóstico y tratamientoEndocarditis fisiopatologia diagnóstico y tratamiento
Endocarditis fisiopatologia diagnóstico y tratamiento
josue946853
 
Endocarditis.ppt
Endocarditis.pptEndocarditis.ppt
Endocarditis.ppt
shirleyjohn4
 
Infective endocarditis in children.pptx
Infective endocarditis in children.pptxInfective endocarditis in children.pptx
Infective endocarditis in children.pptx
SabonaLemessa2
 
Infective endocarditis in children
Infective endocarditis in childrenInfective endocarditis in children
Infective endocarditis in children
birhanu abie
 
INFECTIVE ENDOCARDITIS.pptx
INFECTIVE ENDOCARDITIS.pptxINFECTIVE ENDOCARDITIS.pptx
INFECTIVE ENDOCARDITIS.pptx
HanaaMohamedSheikhOm
 
Ms mr rhd
Ms mr rhdMs mr rhd
Ms mr rhd
Born To Win
 
Rheumatic Heart Disease
 Rheumatic Heart Disease Rheumatic Heart Disease
Rheumatic Heart Disease
Neelu Aryal
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
Kerolus Shehata
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
Sameh Abdel-ghany
 
Endocarditis 2015
Endocarditis  2015Endocarditis  2015
Endocarditis 2015
samirelansary
 
Endocarditis 2015
Endocarditis  2015Endocarditis  2015
Endocarditis 2015
samirelansary
 
infectiveendocarditis-july2015-190917173103.pdf
infectiveendocarditis-july2015-190917173103.pdfinfectiveendocarditis-july2015-190917173103.pdf
infectiveendocarditis-july2015-190917173103.pdf
HaroonButt17
 
Infective endocarditis
Infective endocarditis Infective endocarditis
Infective endocarditis
ikramdr01
 
Infective endocarditis guidelines 2015
Infective endocarditis guidelines 2015Infective endocarditis guidelines 2015
Infective endocarditis guidelines 2015
Rishi Bhargav
 
Rheumatic Heart Disease (RHD)
Rheumatic Heart Disease (RHD)Rheumatic Heart Disease (RHD)
Rheumatic Heart Disease (RHD)
BrahmjotKaur11
 

Similar to INFECTIVE ENDOCARDITIS IN CHILDREN (20)

IEPPT-IIIstd (2).pptx
IEPPT-IIIstd (2).pptxIEPPT-IIIstd (2).pptx
IEPPT-IIIstd (2).pptx
 
infective endocarditis a complete presentation.ppt
infective endocarditis a complete presentation.pptinfective endocarditis a complete presentation.ppt
infective endocarditis a complete presentation.ppt
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Endocarditis.ppt
Endocarditis.pptEndocarditis.ppt
Endocarditis.ppt
 
Endocarditis fisiopatologia diagnóstico y tratamiento
Endocarditis fisiopatologia diagnóstico y tratamientoEndocarditis fisiopatologia diagnóstico y tratamiento
Endocarditis fisiopatologia diagnóstico y tratamiento
 
Endocarditis.ppt
Endocarditis.pptEndocarditis.ppt
Endocarditis.ppt
 
Infective endocarditis in children.pptx
Infective endocarditis in children.pptxInfective endocarditis in children.pptx
Infective endocarditis in children.pptx
 
Infective endocarditis in children
Infective endocarditis in childrenInfective endocarditis in children
Infective endocarditis in children
 
INFECTIVE ENDOCARDITIS.pptx
INFECTIVE ENDOCARDITIS.pptxINFECTIVE ENDOCARDITIS.pptx
INFECTIVE ENDOCARDITIS.pptx
 
Ms mr rhd
Ms mr rhdMs mr rhd
Ms mr rhd
 
Rheumatic Heart Disease
 Rheumatic Heart Disease Rheumatic Heart Disease
Rheumatic Heart Disease
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Endocarditis 2015
Endocarditis  2015Endocarditis  2015
Endocarditis 2015
 
Endocarditis 2015
Endocarditis  2015Endocarditis  2015
Endocarditis 2015
 
Rheumatic heart disease
Rheumatic heart diseaseRheumatic heart disease
Rheumatic heart disease
 
infectiveendocarditis-july2015-190917173103.pdf
infectiveendocarditis-july2015-190917173103.pdfinfectiveendocarditis-july2015-190917173103.pdf
infectiveendocarditis-july2015-190917173103.pdf
 
Infective endocarditis
Infective endocarditis Infective endocarditis
Infective endocarditis
 
Infective endocarditis guidelines 2015
Infective endocarditis guidelines 2015Infective endocarditis guidelines 2015
Infective endocarditis guidelines 2015
 
Rheumatic Heart Disease (RHD)
Rheumatic Heart Disease (RHD)Rheumatic Heart Disease (RHD)
Rheumatic Heart Disease (RHD)
 

More from Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology

PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIASPEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
FETAL CARDIAC SCREENING
FETAL CARDIAC SCREENINGFETAL CARDIAC SCREENING
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIASSYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
PEDIATRIC CARDIOLOGY CASE SCENARIOS
PEDIATRIC CARDIOLOGY CASE SCENARIOSPEDIATRIC CARDIOLOGY CASE SCENARIOS
PEDIATRIC CARDIOLOGY CASE SCENARIOS
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL) PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASESLONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
WHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
WHEN TO REFER TO A PEDIATRIC CARDIOLOGISTWHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
WHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWSPEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTIONWHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
PEDAITRIC OBESITY AND HYPERLIPEDEMIA
PEDAITRIC OBESITY AND HYPERLIPEDEMIAPEDAITRIC OBESITY AND HYPERLIPEDEMIA
PEDAITRIC OBESITY AND HYPERLIPEDEMIA
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 

More from Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology (20)

PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIASPEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
PEDIATRIC SUDDEN CARDIAC DEATH, SYNCOPE, INHERITABLE ARRHYTHMIAS
 
FETAL CARDIAC SCREENING
FETAL CARDIAC SCREENINGFETAL CARDIAC SCREENING
FETAL CARDIAC SCREENING
 
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIASSYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
SYNCOPE, SUDDEN CARDIAC DEATH AND INHERITED ARRHYTHMIAS
 
PEDIATRIC CARDIOLOGY CASE SCENARIOS
PEDIATRIC CARDIOLOGY CASE SCENARIOSPEDIATRIC CARDIOLOGY CASE SCENARIOS
PEDIATRIC CARDIOLOGY CASE SCENARIOS
 
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL) PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
PERCUTANEOUS DEVICE CLOSURE OF AORTO- PULMONARY WINDOW (RESIDUAL)
 
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASESLONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
LONG TERM OUTCOMES OF POST OPERATIVE CHILD WITH CONGENITAL HEART DISEASES
 
WHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
WHEN TO REFER TO A PEDIATRIC CARDIOLOGISTWHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
WHEN TO REFER TO A PEDIATRIC CARDIOLOGIST
 
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWSPEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
PEDIATRIC ECHOCARDIOGRAPHY: APICAL AND PARASTERNAL VIEWS
 
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTIONWHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
WHEN TO REFER A CHILD TO A PEDIATRIC CARDIOLOGIST FOR INTERVENTION
 
PEDAITRIC OBESITY AND HYPERLIPEDEMIA
PEDAITRIC OBESITY AND HYPERLIPEDEMIAPEDAITRIC OBESITY AND HYPERLIPEDEMIA
PEDAITRIC OBESITY AND HYPERLIPEDEMIA
 
Micronutrient deficiency In Children
Micronutrient deficiency In ChildrenMicronutrient deficiency In Children
Micronutrient deficiency In Children
 
DYSBIOSIS IN CHILDREN BORN BY CAESAREAN SECTION
DYSBIOSIS IN CHILDREN BORN BY CAESAREAN SECTIONDYSBIOSIS IN CHILDREN BORN BY CAESAREAN SECTION
DYSBIOSIS IN CHILDREN BORN BY CAESAREAN SECTION
 
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
PEDIATRIC CARDIAC SERVICES IN INDIA: WHERE DO WE ACTUALLY STAND?
 
Heart diseases in children
Heart diseases in childrenHeart diseases in children
Heart diseases in children
 
ICCU ECGs
ICCU ECGsICCU ECGs
ICCU ECGs
 
CONGENITAL HEART DISEASES: A SIMPLIFIED APPROACH
CONGENITAL HEART DISEASES: A SIMPLIFIED APPROACHCONGENITAL HEART DISEASES: A SIMPLIFIED APPROACH
CONGENITAL HEART DISEASES: A SIMPLIFIED APPROACH
 
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
Examination of Cardio Vascular System (CVS): Pediatrics+ APPROACH TO A CHILD ...
 
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
TACHYPNIC NEOANTE: IS IS A CHD: APPROACH TO A CHILD WITH CONGENITAL HEART DIS...
 
Cath meet 25020202 (TGA, VSD, PS FOR PA PRESSURES)
Cath meet   25020202 (TGA, VSD, PS FOR PA PRESSURES)Cath meet   25020202 (TGA, VSD, PS FOR PA PRESSURES)
Cath meet 25020202 (TGA, VSD, PS FOR PA PRESSURES)
 
Cath meet 03022020 (VSD PAH FOR REVERSIBILITY, PVR)
Cath meet 03022020 (VSD PAH FOR REVERSIBILITY, PVR)Cath meet 03022020 (VSD PAH FOR REVERSIBILITY, PVR)
Cath meet 03022020 (VSD PAH FOR REVERSIBILITY, PVR)
 

Recently uploaded

How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 

Recently uploaded (20)

How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 

INFECTIVE ENDOCARDITIS IN CHILDREN

  • 1. PRESIDENTIAL ACTION PLAN 2018 Ref: INFECTIVE ENDOCARDITIS IN CHILDREN MURTAZA KAMAL 5TH JAN, 2019
  • 2. PRESIDENTIAL ACTION PLAN 2018 Ref:  Definition  Epidemiology  Pathogenesis/ Pathology/ Microbiology  Clinical features  Diagnosis & Diagnostic criteria  Treatment  Preventive methods Scope of the talk…
  • 3. PRESIDENTIAL ACTION PLAN 2018 Ref:  Microbial infection of endocardial (endothelial) surface of heart  Native/ prosthetic valves: Most frequently involved  Can involve septal defects, mural endocardium, intravascular foreign devices, intracardiac patches, surgically constructed shunts, IV catheters  Disease classification on basis of etiologic agent involved:  Low virulence organisms (Alpha hemolytic streptococcai, enterococci, CONS): Prolonged subacute form of illness  Virulent organisms (Staph aureus, strept pneumoniae, beta hemolytic streptococci): Acute clinical course Definition Gewitz M, Taubert KA. IE and prevention. In: Heart disease in infant, children andadolescents. 9th ed. Philadelphia: Wolter Kluwer; 2016: 1441-1453
  • 4. PRESIDENTIAL ACTION PLAN 2018 Ref:  Less often in children than in adults  1: 1280 (0.78/1000) paediatric admissions/ year  Overall frequency among children and a shift towards those with previous cardiac surgery: Increased Improved survival among children who are at risk of IE, such as those with CHD (with/ without surgery) and hospitalised neonates  CHD: Predominant underlying condition in developed world (MC: VSD, TOF, aortic valve abnormalities)  Post operative IE: Long term risk after correction of complex CHD, esp those with residual defects/ surgical shunts/ prosthetic materials Epidemiology Van Hare GF, Ben-Shachar G, Liebman J, Boxerbaum B, RiemenschneiderTA. Infective endocarditis in infants and children during the past 10 years: a decade of change. Am Heart J. 1984;107:1235–1240. Pasquali SK, He X, Mohamad Z, McCrindle BW, Newburger JW, Li JS,Shah SS. Trends in endocarditis hospitalizations at US children’s hospitals: impact of the 2007 American Heart Association antibiotic prophylaxisguidelines. Am Heart J 2012;143:894–899.
  • 5. PRESIDENTIAL ACTION PLAN 2018 Ref:  RHD: Before 1970s, 30-50% children with IE  Decreased now as prevalence of RHD decreased in developed countries  8-10% of pediatric cases: IE develops without structural heart disease: Central indwelling venous catheters Mostly aortic or mitral valves are involved by staph aureus  Neonates: 7.3% cases: Right sided heart structures involved  Factors associated with IE in adults like IV drug abuse and degenerative heart diseases: Not common predisposing factor Epidemiology Cont… Baltimore RS. Infective endocarditis. In: Jenson HB, Baltimore RS,eds. Pediatric Infectious Diseases: Principles and Practice. 2nd ed. Philadelphia, PA: Saunders; 2002. Stull TL, LiPuma JJ. Endocarditis in children. In: Kaye D, ed. InfectiveEndocarditis. 2nd ed. New York, NY: Raven Press; 1992:313–327 Stockheim JA, Chadwick EG, Kessler S, Amer M, Abdel-Haq N, DajaniAS, Shulman ST. Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children? Clin Infect Dis.1998;27:1451–1456.
  • 6. PRESIDENTIAL ACTION PLAN 2018 Ref:  2 important factors:  Damaged area of endothelium and  Bacteremia (even transient)  Structural abnormalities of heart/ great arteries+ significant pressure gradient/ turbulence Endothelial damage Thrombus formation with deposition of sterile clumps of platelet and fibrin Nonbacterial thrombus Nidus for bacteria to adhere and form infected vegetation  Bacteremia from dental procedures  Bacteremia with activities such as chewing/ brushing teeth  Chewing with diseased teeth or gums frequent cause of bacteremia  Good dental hygiene very important in prevention Pathogenesis
  • 7. PRESIDENTIAL ACTION PLAN 2018 Ref: Vegetation:  Usually on low-pressure side of defect  Either around defect or on opposite surface of defect where endothelial damage is established by jet effect of defect  Vegetations found in PA in PDA or systemic-to-PA shunts  On atrial surface of mitral valve in MR  On ventricular surface of aortic valve and mitral chordae in AR  On superior surface of aortic valve or at site of a jet lesion in aorta in AS Pathology
  • 8. PRESIDENTIAL ACTION PLAN 2018 Ref:  Streptococcus viridans, Enterococci and Staphylococcus aureus: 50%- 60%  Fungi+ HACEK organisms (Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, and Kingella spp.): 17% to 30%  α-Hemolytic streptococci (S. viridans): Dental procedures/ carious teeth/ periodontal disease  Enterococci: After GU/ GI surgery/ instrumentation  Staphyloccocci: Postoperative endocarditis  S. aureus: IV drug abusers  Fungal endocarditis (poor prognosis): Sick neonates/ long- term antibiotic or steroid therapy/ after open heart surgery  Fungal endocarditis: Associated with very large friable vegetations; emboli from these vegetations frequently produce serious complications Microbes: The Agent
  • 9. PRESIDENTIAL ACTION PLAN 2018 Ref:  S. aureus/ CONS: Indwelling vascular catheters/ prosthetic material/ prosthetic valves  S. aureus/ CONS/ Candida: MCC among newborn infants  Culture-negative endocarditis: 5-7%  Patient has clinical or echo evidence of endocarditis but persistently negative blood culture results  MCC: Current or recent antibiotic therapy or infection caused by a fastidious organism that grows poorly in vitro  Fungal endocarditis: A rare cause of culture-negative endocarditis  Diagnosis can be made only by removal of vegetation (during surgery) sometimes Microbes: The Agent…
  • 10. PRESIDENTIAL ACTION PLAN 2018 Ref:  Most patients have history of underlying heart defect  Some patients with bicuspid aortic valve may not have been diagnosed with defect before  History of a recent dental procedure/ tonsillectomy / toothache (from dental or gingival disease)  Endocarditis: Rare in infancy; at this age, usually follows open heart surgery  Onset usually insidious with prolonged low-grade fever and somatic complaints, fatigue, weakness, loss of appetite, pallor, arthralgia, myalgias, weight loss, and diaphoresis Clinical Features: History
  • 11. PRESIDENTIAL ACTION PLAN 2018 Ref:  Heart murmur: Universal (100%)  Appearance of new heart murmur/ Increase in intensity of an existing murmur  Fever: 80%–90%; 101° and 103°F  Splenomegaly: 70%  Skin manifestations: 50%; Either secondary to microembolization or as an immunologic phenomenon:  Petechiae on skin/ mucous membranes/ conjunctivae  Osler’s nodes: Tender, pea-sized red nodes at ends of fingers/ toes  Janeway’s lesions: Small, painless, hemorrhagic areas on palms/ soles  Splinter hemorrhages: Linear hemorrhagic streaks beneath nails Clinical Features: Examination
  • 12. CLINICAL FEATURES: EXAMINATION Osler Nodes Janeway lesion From AAP. Red Book Online visual library, 2006
  • 13. PRESIDENTIAL ACTION PLAN 2018 Ref: Clinical Features: Examination  Embolic/ immunologic phenomena in other organs: 50%  Pulmonary emboli: VSD, PDA or a systemic-to-PA shunt  Seizures and hemiparesis: Embolization to CNS-20%  Hematuria and renal failure  Roth’s spots- 5%: Oval, retinal hemorrhages with pale centers located near optic disc From AAP. Red Book Online visual library, 2006
  • 14. PRESIDENTIAL ACTION PLAN 2018 Ref: Clinical Features: Examination  Clubbing of fingers in absence of cyanosis rarely in chronic cases  Heart failure as a complication of infection  Neonate:  Nonspecific and may be indistinguishable from septicemia or CHF from other causes  Embolic phenomena (osteomyelitis, meningitis) common  Neurologic signs and symptoms (seizures,hemiparesis, apnea)
  • 15. PRESIDENTIAL ACTION PLAN 2018 Ref:  Positive blood cultures:  90% in absence of previous antimicrobial therapy  50-60% pretreatment with antibiotics  CBC:  Anemia: 80%  Leukocytosis with a shift to the left  Patients with polycythemia preceding onset of IE may have normal hemoglobin  ESR: Increased unless there is polycythemia.  Microscopic hematuria: 30% Lab Studies
  • 16. PRESIDENTIAL ACTION PLAN 2018 Ref:  Main modality for detection  Site of infection, extent of valvular damage and cardiac function  Baseline evaluation of ventricular function and cardiac chamber dimension important for comparison later  Color Doppler: Sensitive modality for detection of valvular regurgitation Role of ECHOCARDIOGRAPHY Vegetations on the aortic valve
  • 17. PRESIDENTIAL ACTION PLAN 2018 Ref:  Echocardiographic findings included as major criteria in modified Duke criteria:  Oscillating intracardiac mass on valves or supporting structures, in path of regurgitation jets, or on implanted material  Abscesses  New partial dehiscence of prosthetic valve  New valvular regurgitation Role of ECHOCARDIOGRAPHY
  • 18. PRESIDENTIAL ACTION PLAN 2018 Ref:  TEE superior to TTE:  Vegetations on prosthetic valves  Detecting complications of LV outflow tract endocarditis  Detecting aortic root abscess and involvement of sinus of Valsalva  Absence of vegetations on echo: Does not rule out IE  False-negative: Vegetations are small or have embolized and they may miss initial perivalvular abscess  Repeat examinations indicated if suspicion exists without diagnosis of IE or worrisome clinical course during early treatment of IE Role of ECHOCARDIOGRAPHY
  • 19. PRESIDENTIAL ACTION PLAN 2018 Ref:  False-positive:  An echogenic mass may represent a sterile thrombus, sterile prosthetic material, normal anatomic variation, an abnormal uninfected valve (previous scarring, severe myxomatous changes), or improper gain of echo machine  Echocardiographic evidence of vegetation may persist for months or years after bacteriologic cure Role of ECHOCARDIOGRAPHY
  • 20. PRESIDENTIAL ACTION PLAN 2018 Ref: Echocardiographic Features Suggesting Potential Need for Surgical Intervention Bayer et al.102 Copyright © 1998, American Heart Association, Inc.
  • 21. PRESIDENTIAL ACTION PLAN 2018 Ref:  Definite IE :  Pathological evidence of IE:  Demonstration of microorganism by culture  Histology in a vegetation or from an embolic sites or an intracardiac abscess or histologic evidence of active endocarditis demonstrated in vegetation or intracardiac abscess  Fulfillment of clinical criteria:  2 major criteria  1 major+ 3 minor criteria  5 minor criteria DIAGNOSIS: Modified Dukes Criteria
  • 22. PRESIDENTIAL ACTION PLAN 2018 Ref:  Possible IE: When one of the following is present:  1 major+ 1 minor criterion  3 minor criteria  Rejected IE:  An alternative diagnosis is established  Clinical manifestations of IE have resolved within 4 days of antibiotic therapy  No pathological evidence is found on direct examination of vegetation obtained from surgery or autopsy after antibiotic therapy for < 4 days  Criteria for possible IE are not met DIAGNOSIS: Modified Dukes Criteria
  • 23. PRESIDENTIAL ACTION PLAN 2018 Ref: 1. Blood culture positive for IE:  Typical microorganisms consistent with IE from 2 separate blood cultures: Viridans streptococci, Streptococcus bovis, HACEK group, Staphylococcus aureus; or community- acquired enterococci in absence of a primary focus or  Microorganisms consistent with IE from persistently positive blood cultures defined as: at least 2 positive cultures of blood samples drawn >12 h apart or all of 3 or a majority of 4 or more separate cultures of blood (with first and last sample drawn at least 1 h apart)  Single positive blood culture for Coxiella burnetii or anti– phase 1 IgG antibody titer >1:800 Modified Dukes: Major Criteria
  • 24. PRESIDENTIAL ACTION PLAN 2018 Ref: 2. Evidence of endocardial involvement  Echocardiogram positive for IE (TEE recommended for patients with prosthetic valves, rated at least “possible IE” by clinical criteria, or complicated IE [paravalvular abscess]; TTE as first test in other patients) defined as follows:  Oscillating intracardiac mass on valve or supporting structures, in path of regurgitant jets, or on implanted material in absence of an alternative anatomic explanation  Abscess  New partial dehiscence of prosthetic valve  New valvular regurgitation (worsening or changing or preexisting murmur not sufficient) Modified Dukes: Major Criteria
  • 25. PRESIDENTIAL ACTION PLAN 2018 Ref:  Predisposition, predisposing heart condition, or IDU  Fever, temperature >38°C  Vascular phenomena: Major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages and Janeway’s lesions  Immunologic phenomena: Glomerulonephritis, Osler’s nodes, Roth’s spots and rheumatoid factor  Microbiologic evidence: Positive blood culture but does not meet a major criterion or serologic evidence of active infection with organism consistent with IE Modified Dukes: Minor Criteria
  • 26. PRESIDENTIAL ACTION PLAN 2018 Ref:  Blood cultures: Indicated for all patients with fever of unexplained origin and a pathologic heart murmur, a history of heart disease or previous endocarditis  Usually 3 blood cultures are drawn by separate venipunctures over 24 hours unless patient is very ill  90% of cases, causative agent is recovered from 1st 2 cultures  If no growth by 2nd day of incubation, 2 more may be obtained  No value in obtaining >5 blood cultures over 2 days unless patient received prior antibiotic therapy  Not necessary to obtain cultures at any particular phase of fever cycle  Adequate volume: 1-3 mL infants; 5-7 mL older children  Aerobic incubation alone sufficient Management
  • 27. PRESIDENTIAL ACTION PLAN 2018 Ref:  Recommended that consultation from local infectious disease specialist be obtained when IE suspected/confirmed: Antibiotics of choice continually changing, and there may be special situation pertaining to local area  Initial empirical therapy:  Usual initial regimen: Antistaphylococcal semisynthetic penicillin (nafcillin,oxacillin or methicillin)+ aminoglycoside (gentamicin)  Covers against S. viridans, S. aureus, and gram-negative organisms  Vancomycin:  Methicillin-resistant S. aureus suspected  Penicillin-allergic patients Management
  • 28. PRESIDENTIAL ACTION PLAN 2018 Ref:  Depends on organism isolated+ results of antibiotic sensitivity test  Streptococcal IE:  Native cardiac valve IE caused by highly sensitive S. viridans:  IV penicillin (or ceftriaxone OD) X 4 weeks  Alternatively penicillin, ampicillin or ceftriaxone+ gentamicin for 2 weeks  IE caused by penicillin-resistant streptococci:  4 weeks of penicillin, ampicillin or ceftriaxone+ gentamicin for 2 weeks Final antibiotic selection
  • 29. PRESIDENTIAL ACTION PLAN 2018 Ref:  Staphylococcal endocarditis:  Drug of choice native valve IE by methicillin-susceptible staphylococci: Semisynthetic β-lactamase–resistant penicillins (nafcillin, oxacillin or methicillin) X minimum of 6 weeks (± gentamicin X 3–5 days)  Methicillin-resistant native valve IE: Vancomycin X 6 weeks (± gentamicin X 3–5 days)  Enterococcus:  IV penicillin/ ampicillin+ gentamicin X 4 to 6 weeks  Allergic to penicillin: Vancomycin +gentamicin x 6 weeks  HACEK organisms:  Ceftriaxone/ another 3rd generation cephalosporin alone or ampicillin+ gentamicin x 4 weeks Final antibiotic selection
  • 30. PRESIDENTIAL ACTION PLAN 2018 Ref:  IE by other gram-negative bacteria (E coli, Pseudomonas aeruginosa, or Serratia marcescens):  Piperacillin/ ceftazidime together+ gentamicin X 6 weeks  Amphotericin B: Most effective agent for most fungal infections  Culture-negative endocarditis:  Treatment directed against staphylococci, streptococci and HACEK organisms using ceftriaxone+ gentamicin  When staphylococcal IE suspected, nafcillin should be added to the above therapy Final antibiotic selection
  • 31. PRESIDENTIAL ACTION PLAN 2018 Ref:  Should be treated for 6 weeks based on organism isolated and results of sensitivity test  Operative intervention may be necessary before antibiotic therapy is completed if clinical situation warrants:  Progressive CHF  Significant malfunction of prosthetic valves  Persistently positive blood cultures after 2 weeks of therapy  Bacteriologic relapse after an appropriate course of therapy Prosthetic valve Endocarditis
  • 32. PRESIDENTIAL ACTION PLAN 2018 Ref:  Overall recovery rate: 80%- 85%  90% or better: S. viridans and enterococci  50%: Staphylococcus organisms  Fungal endocarditis: Very poor outcome Prognosis
  • 33. PRESIDENTIAL ACTION PLAN 2018 Ref: Prevention  Emphasis should be on maintaining good oral hygiene and eradicating dental disease to decrease frequency of bacteremia from routine daily activities  Recommended for tonsillectomy and adenoidectomy only in high-risk patients  Prophylaxis no longer recommended:  For routine bronchoscopy  For GI or genitourinary procedures, such as diagnostic esophagogastroduodenoscopy or colonoscopy
  • 34. PRESIDENTIAL ACTION PLAN 2018 Ref:  Patients with prosthetic cardiac valve/ material used for cardiac valve repair  Patients with previous IE  Patients with CHD:  Unrepaired cyanotic CHD, including palliative shunts/ conduits  Completely repaired CHD with prosthetic material/ device, whether placed by surgery or catheter intervention, during 1st 6 months after procedure  Repaired CHD with residual defects at site or adjacent to site of a prosthetic patch/ device (which inhibits endothelialization)  Cardiac transplantation recipients with valve regurgitation caused by a structurally abnormal valve Cardiac conditions for which prophylaxis With dental procedures is recommended
  • 35. PRESIDENTIAL ACTION PLAN 2018 Ref:  Dental procedures:  Involving manipulation of gingival tissue of periapical region or perforation of oral mucosa  Respiratory tract procedures:  Procedures that involve incision/ biopsy of respiratory mucosa  Not recommended for bronchoscopy  GI or GU procedures:  No prophylaxis for diagnostic esophagogastroduodenoscopy/ colonoscopy  Reasonable in patients with infected GI/GU tract  Skin, skin structure or musculoskeletal tissue:  Surgical procedures that involve infected skin, skin structure, or musculoskeletal tissue Procedures for which IE Prophylaxis is recommended
  • 36. PRESIDENTIAL ACTION PLAN 2018 Ref: Prophylactic regimens for Dental procedures Park. Pediatric cardiology for practitioners; 6th edition
  • 37. PRESIDENTIAL ACTION PLAN 2018 Ref: Special Considerations  Patients already receiving antibiotics:  Rheumatic fever prophylaxis: Use other antibiotics, such as clindamycin, azithromycin or clarithromycin  Delay a procedure until 10 days after completion of antibiotic  Patients who undergo cardiac surgery:  Careful preoperative dental evaluation so that required dental treatment may be completed whenever possible before surgery  Prophylaxis at time of surgery: Primarily against staphylococci Prophylaxis should be initiated immediately before surgery, repeated during prolonged procedures to maintain serum concentrations intraoperatively, and continued for no more than 48 hours postoperatively
  • 38. PRESIDENTIAL ACTION PLAN 2018 Ref:  IE in children is not uncommon  Common in children with CHD  Neonates: Poor outcome  Blood culture + ECHO has important role in diagnosis  Treatment adherence necessary  Prognosis not bad if treated properly  Knowledge of conditions requiring prophylaxis and drugs for it necessary Take Home Message
  • 39. PRESIDENTIAL ACTION PLAN 2018 Ref: THANK YOU